Theodore A. Omachi MD
Critical Care Medicine
Medical Director, Genentech and Volunteer Faculty, UCSF
Join to view full profile
3333 California StUCSF Suite 270San Francisco, CA 94118
Phone+1 475-476-6926
Fax+1 415-814-5770
Dr. Omachi is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California (San Francisco)Fellowship, Pulmonary Disease and Critical Care Medicine, 2005 - 2008- University of California (San Francisco)Residency, Internal Medicine, 2002 - 2005
University of California San Diego School of MedicineClass of 2002
Certifications & Licensure
CA State Medical License 2004 - 2028
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory EHR Suite, Epic Systems Corporation, 2013, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013, 2016-2017
Publications & Presentations
PubMed
- 5 citationsObinutuzumab or Tacrolimus in Primary Membranous Nephropathy.Fernando C Fervenza, Fan Fan Hou, Chuan-Ming Hao, Gianna M Kirsztajn, Loreto Gesualdo
The New England Journal of Medicine. 2026-09-10 - 1 citationsPhase Ib, multicentre, open-label, dose-escalation study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of subcutaneously administered mos...Elsa Martins, Vishala L Chindalore, X Rebecca Sheng, Aaron V Schroeder, Vivian Chen
Lupus Science & Medicine. 2026-06-17 - 144 citationsEfficacy and Safety of Obinutuzumab in Active Lupus Nephritis.Richard A Furie, Brad H Rovin, Jay P Garg, Mittermayer B Santiago, Gustavo Aroca-Martínez
The New England Journal of Medicine. 2025-04-17
Grant Support
- The Overlap Syndrome Of COPD And OSA: Determinants Of Health Status And OutcomesNational Heart, Lung, And Blood Institute2010–2011
- Assessment And Prediction Of Costs And Adverse Health Outcomes In COPDAgency For Healthcare Research And Quality2008
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: